Gemini 3.5 Pro isn't coming out yet, disappointing the crowd at Google's packed flagship developer conference I/O on Tuesday. "I know you can't wait to get your hands on it," CEO Sundar Pichai said ...

For all its driverless cars, AI chips, and fitness trackers, Search is still Google's most important product. That's why it's a big deal any time Google makes a change to its search engine — ...

At Google IO 2026, the company unveiled a new version of its agentic coding app, Google Antigravity 2.0, with an updated desktop app, a CLI tool, and an SDK for custom workflows. The company launched ...

Soon you'll be able to literally talk to your Gmail inbox. During its I/O keynote today, Google unveiled a new native AI voice integration feature for Gmail called Gmail Live. The tool will let users ...

In February, numerous workers from a company that Meta contracted to perform data annotation for Ray-Ban Meta reported viewing sensitive, embarrassing, and seemingly private footage recorded by the ...

Someone stole 15 giant agricultural drones in New Jersey — and experts fear a “nightmare scenario” if they end up in the hands of terrorists. The fleet of Ceres Air C31 drones, which are about the ...

NEW YORK, NY, April 16, 2026 (EZ Newswire) -- Lemon.io, opens new tab’s new report, “The Four Essential AI Engineering Roles for 2026,” reveals how the once-unified “AI engineer” title has fragmented ...

Booking.com confirmed unauthorized access to guest booking information, underscoring risks as stolen travel data circulates on criminal forums. The Booking.com data breach prompted reservation PIN ...

We're sliding into developer conference season and one of the biggest events on the upcoming calendar is Google I/O. This year's edition is taking place on May 19 and 20. As usual, the in-person ...

Stablecoins dominated crypto trading in Q1 as investors sought safety, while rising bot usage and declining retail flows pointed to shifting market dynamics, according to CEX.IO. Stablecoins were a ...

The FDA advised IO Biotech last year to hold off on filing an approval application for its cancer vaccine Cylembio, pointing to a failed Phase 3 study in frontline advanced melanoma. The biotech has ...

Half a year after being spurned by the FDA and following deep layoffs, IO Biotech has decided to close its doors for good. The Danish biotech has ceased operations and said goodbye to its employees, C ...